TGFB1 and lung carcinoma: It was revealed that TGF-β can up-regulate the expression of HSP27 and cisplatin resistance in human lung cancer cell through blocking the cisplatin-induced apoptosis and cell death, which characterized as the increasing of cell viability and decreasing of PARP and caspase3 cleavage in the cisplatin-treated cell.